Seeing Is Believing
ARTL is currently covered by 1 analysts
Artelo Biosciences's activity chart (see below) currently has 27 price targets and 29 ratings on display. The stock rating distribution of ARTL is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 84.2 days.
Highest price target for ARTL is $50, Lowest price target is $50.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 18-Nov-2025. First documented stock forecast 09-Jul-2019.
Currently out of the existing stock ratings of ARTL, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Jul-2019
$12149.98
11 months 2 days ago
(18-Nov-2025)
0/2 (0%)
$4908.58 (67.78%)
Buy Since 04-Aug-2025
$18
1 years 1 months 12 days ago
(08-Sep-2025)
5/5 (100%)
$-9.09 (-33.55%)
103
Buy Since 02-Nov-2021
$270.54
$267.84 (9920.00%)
1 years 7 months 17 days ago
(03-Mar-2025)
1/2 (50%)
$102.87 (61.35%)
118
Buy Since 12-Feb-2021
$630
3 years 6 months 18 days ago
(03-Apr-2023)
0/1 (0%)
$390.6 (163.16%)
What is ARTL (Artelo Biosciences) average time for price targets to be met?
Which analyst most recently updated their price target on ARTL (Artelo Biosciences)?
Which analyst has the current lower performing score on ARTL (Artelo Biosciences) with a proven track record?
Which analyst has the most public recommendations on ARTL (Artelo Biosciences)?
Which analyst is the currently most bullish on ARTL (Artelo Biosciences)?
Which analyst is the currently most reserved on ARTL (Artelo Biosciences)?